betaxolol has been researched along with fluorescein in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arend, O; Cantor, L; Chung, HS; Harris, A; Kagemann, L; Martin, B | 1 |
1 trial(s) available for betaxolol and fluorescein
| Article | Year |
|---|---|
A comparative study of betaxolol and dorzolamide effect on ocular circulation in normal-tension glaucoma patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Betaxolol; Blood Flow Velocity; Carbonic Anhydrase Inhibitors; Cross-Over Studies; Female; Fluorescein; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Artery; Ophthalmic Solutions; Retinal Artery; Sulfonamides; Thiophenes; Ultrasonography, Doppler, Color | 2000 |